title: Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains.
abstract: Dextran sulfate (DS), a negatively charged, sulfated polysaccharide, suppresses the replication of an influenza A virus strain, and this suppression is associated with inhibition of the hemagglutinin (HA)-dependent fusion activity. However, it remains unknown whether the replication of all or just some influenza A virus strains is suppressed by DS, or whether HA is the only target for the replication suppression. In the present study, we found that DS inhibited the replication of some, but not all influenza A virus strains. The suppression in the DS-sensitive strains was dose-dependent and neutralized by diethylaminoethyl-dextran (DD), which has a positive charge. The suppression by DS was observed not only at the initial stage of viral infection, which includes viral attachment and entry, but also at the late stage, which includes virus assembly and release from infected cells. Electron microscopy revealed that the DS induced viral aggregation at the cell surface. The neuraminidase (NA) activity of the strains whose viral replication was inhibited at the late stage was also more suppressed by DS than that of the strains whose replication was not inhibited, and this inhibition of NA activity was also neutralized by adding positively charged DD. Furthermore, we found that replacing the NA gene of a strain in which viral replication was inhibited by DS at the late stage with the NA gene from a strain in which viral replication was not inhibited, eliminated the DS-dependent suppression. These results suggest that the influenza virus NA contributes to the DS-suppressible virus release from infected cells at the late stage, and the suppression may involve the inhibition of NA activity by DS's negative charge.
authors.affiliation: Laboratory of Virology and Vaccinology, Division of Biomedical Research, National Institute of Biomedical Innovation, Ibaraki, Osaka, Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Yamada
authors.forename: Eiko
authors.initials: E
authors.lastname: Moriishi
authors.forename: Ahmad M
authors.initials: AM
authors.lastname: Haredy
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Takenaka
authors.forename: Yasuko
authors.initials: Y
authors.lastname: Mori
authors.forename: Koichi
authors.initials: K
authors.lastname: Yamanishi
authors.forename: Shigefumi
authors.initials: S
authors.lastname: Okamoto
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D003637:DEAE-Dextran / Q000494:pharmacology; D016264:Dextran Sulfate / Q000494:pharmacology*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation; D057809:HEK293 Cells; D006801:Humans; D009980:Influenza A virus / Q000187:drug effects* / Q000201:enzymology / Q000502:physiology; D061985:Madin Darby Canine Kidney Cells; D009439:Neuraminidase / Q000378:metabolism*; D009500:Neutralization Tests; D016865:Reassortant Viruses / Q000378:metabolism; D055672:Static Electricity; D010948:Viral Plaque Assay; D057074:Virus Release / Q000187:drug effects; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D003637:DEAE-Dextran; D016264:Dextran Sulfate; D009439:Neuraminidase